Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Ankara University, Ankara, Turkey

2 abstracts

Abstract
Daratumumab (DARA) + bortezomib/lenalidomide/dexamethasone (VRd) in transplant-eligible (TE) patients (pts) with newly diagnosed multiple myeloma (NDMM): Analysis of minimal residual disease (MRD) in the PERSEUS trial.
Org: Department of Hematology, Cancer Center Clínica Universidad de Navarra, Pamplona, Spain, Hematology Department, University Hospital Hôtel-Dieu, Nantes, France, National and Kapodistrian University of Athens, Athens, Greece, Ankara University, Ankara, Turkey, CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France,
Abstract
ASSOCIATION BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) IN PROSPECTIVE GENES AND SUSCEPTIBILITY TO ANKYLOSING SPONDYLITIS, INFLAMMATORY BOWEL DISEASE IN A TURKISH POPULATION
Org: Rheumatology, Yıldırım Beyazıt University, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Gastroenterology Department, Immunology and Allergy, Ankara University, Ankara, Rheumatology, Cumhuriyet University, Sivas,